Abstract:Background: During pregnancy metabolic disorders that affect differently the fetus, are known. These could be early or late disorders. Objectives: To analyze different biochemical parameters in umbilical cord blood (UCB) of healthy and pathological newborns from mothers with metabolic disorders. Materials and methods: Samples from UCB (121) were analyzed of newborn from mothers with metabolic disorders who attended at Obstetrics Division. Patients were consecutive, prospective and transversally studied. Newborn were classified as healthy (n = 65) and pathological (n = 56). The maternal metabolic disorders were gestational or non-gestational diabetes, glucose intolerance, insulin resistance and/or obesity).The disorders of the pathological newborns were intrauterine growth restriction (IUGR) and/or fetal distress. Glucose (Glu), urea, creatinine, uric acid (UA), total bilirubin (TB), total proteins (TP), albumin (Alb), transaminases (ALT/AST), alkaline-phosphatase (ALP), gammaglutamyltranspeptidase (GGT), creatinkinasa (CK), lactatedehydrogenase, amylase (amy), pseudocholinesterase, iron, calcium, phosphorus, magnesium (Mg), sodium, potassium, chlorine, cholesterol (Chol), HDL-Chol, LDL-Chol, triglycerides (TG), high sensitivity C reactive protein (hsCRP) were determined by recommended methods. T-Student's and Mann Withney tests were applied, p < .05. Results: Pathological neonates (n: 56) showed a significant decrease in maternal gestation weeks (GW) and in newborn weight (NW) with respect to healthy newborns (n: 65) from mothers with metabolic disorders (p < .0001). Pathological neonates from mothers with metabolic pathologies (n: 56) showed significant increases in Chol, TG, TB (p < .01), LDL-Chol, UA, Mg, hsCRP, ALP levels (p < .05) and significant decreases in TP, Alb (p < .0001) and Glu, ALT, CK, GGT, amy (p < .05) in UCB with respect to healthy newborns. Conclusions: In pathological newborn, the decrease in GW and NW would be related to IUGR that accompany these metabolic disorders. The increases observed of the analyzed parameters would be related to cellular destruction associated to maternal pathology and decreases of the parameters to IUGR with hepatic immaturity.

Study on the relationship between selective intrauterine growth restriction (sIUGR) and metabolic disorder-Metabonomics Study of cord blood based on gas chromatography time-of-flight mass spectrometry (GC-TOF/MS)

Metabolic Biomarkers of Monochorionic Twins Complicated with Selective Intrauterine Growth Restriction in Cord Plasma and Placental Tissue

Preliminary analysis of metabonomics in selective intrauterine growth restriction with abnormal umbilical artery Doppler flow

Cord Blood Adiponectin and Leptin Concentrations in Monochorionic Twins with Selective Intrauterine Growth Restriction and Their Associations with Childhood Growth Trajectories

Neonatal Hair Profiling Reveals a Metabolic Phenotype of Monochorionic Twins with Selective Intrauterine Growth Restriction and Abnormal Umbilical Artery Flow

[Metabolomic Network Analysis of Umbilical Cord Blood of Gestational Diabetes Mellitus Patients Via Liquid Chromatography-Mass Spectrometry].

MicroRNA Expression Profiles and Networks in Placentas Complicated with Selective Intrauterine Growth Restriction.

Biochemical profiling study in umbilical cord blood in mothers with metabolic disorders

Investigation of newborn blood metabolomics in varying intrauterine growth conditions

Metabolic Dynamics and Prediction of Sfgr and Adverse Fetal Outcomes: a Prospective Longitudinal Cohort Study.

Metabolomic profiling of human feces and plasma from extrauterine growth restriction infants

Metabolomic Analysis Reveals Differences In Umbilical Vein Plasma Metabolites Between Normal And Growth-Restricted Fetal Pigs During Late Gestation

Human cord plasma proteomic analysis reveals sexually dimorphic proteins associated with intrauterine growth restriction

Cord Blood C-peptide, Insulin, HbA1c, and Lipids Levels in Small- and Large-for-Gestational-Age Newborns

Amniotic fluid metabolic fingerprinting contributes to shaping the unfavourable intrauterine environment in monochorionic diamniotic twins.

Assessment of the Placenta in Intrauterine Growth Restriction by Diffusion-Weighted Imaging and Proton Magnetic Resonance Spectroscopy: A Pilot Study

Analysis of Gene Expression Profiles in the Liver of Rats With Intrauterine Growth Retardation

Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation

Proton Magnetic Resonance Spectroscopy Assessment of Fetal Brain Metabolism in Late-Onset ‘Small for Gestational Age' versus ‘Intrauterine Growth Restriction' Fetuses

Assessment of the Placenta in Intrauterine Growth Restriction by Diffusion-Weighted Imaging and Proton Magnetic Resonance Spectroscopy

Maternal Utero-Placental Perfusion Discordance in Monochorionic-Diamniotic Twin Pregnancies with Selective Growth Restriction Assessed by Three-Dimensional Power Doppler Ultrasound